AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Glysuit M2 Tablet SR

Prescription Icon
Prescription Required

Marketer

Bio Schutz Pharmaceuticals Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glysuit M2 Tablet SR

DiabetaComb SR tablets are antidiabetic medications, a dual-drug formulation for adult type 2 diabetes management. They help regulate blood glucose. Take DiabetaComb SR with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continue taking this medication even with controlled blood sugar; discontinuation without medical advice can lead to elevated glucose, risking kidney complications, vision loss, neuropathy, and limb amputation. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor; lifestyle choices significantly impact diabetes control. The most prevalent adverse effect is hypoglycemia (low blood sugar). Learn to recognize its symptoms—sweating, dizziness, headache, trembling—and how to manage them. Consistent meals and readily available fast-acting glucose sources (e.g., sugary foods, juice) are essential. Alcohol increases hypoglycemia risk and should be avoided. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain is possible. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Inform your doctor of any history of heart disease before use; it may be unsuitable. Pregnant or lactating women should consult their physician prior to use. Regular blood glucose monitoring is necessary, along with potential blood tests to assess blood cell counts and liver function.

Primary Ingredients of Glysuit M2 Tablet SR

The information is unavailable.

Uses of Glysuit M2 Tablet SR

Managing Type 2 Diabetes

Major Benefits of Glysuit M2 Tablet SR:

Follow your physician's instructions precisely regarding dosage and treatment length for Glysuit M2 Tablet SR. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. This medication should be administered with a meal.

Common Side effects of Glysuit M2 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glysuit M2 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Glysuit M2 Tablet SR. Ingest the tablet whole; do not crush, chew, or divide it. Administer this medication with food.

How Glysuit M2 Tablet SR works:

Glysuit M2 SR tablets contain a dual-action antidiabetic formulation: glimepiride and metformin. Glimepiride, a sulfonylurea, enhances pancreatic insulin secretion, thereby reducing blood sugar levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose uptake, and improving insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol concurrently with Glysuit M2 Tablet SR is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glysuit M2 Tablet SR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Glysuit M2 sustained-release tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Impaired driving is possible with both hypo- and hyperglycemia. Refrain from driving if these conditions arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glysuit M2 Tablet SR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Renal function should be regularly monitored during treatment; physician consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should use Glysuit M2 Tablet SR cautiously, potentially requiring dose modification. Consult a physician. A low starting dose is typically advised for individuals with mild to moderate liver disease; this medication is contraindicated in those with severe hepatic dysfunction.

What if you forget to take Glysuit M2 Tablet SR :

Should you forget a Glysuit M2 Tablet SR dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glysuit M2 Tablet SR

LabelValue
Potential for Dependence None.
Type of Treatment Medication for diabetes

FAQs on Glysuit M2 Tablet SR

Maintain this medication within its original, sealed container. Follow the storage guidelines provided on the packaging. Discard any remaining medication. Prevent access by children, animals, and unauthorized individuals.
Glysuit M2 Tablet SR carries a risk of lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed MALA (Metformin-associated lactic acidosis), this rare but potentially harmful side effect is particularly concerning for individuals with impaired kidney function, the elderly, and those who consume significant amounts of alcohol. Symptoms can manifest as muscle aches or weakness, lightheadedness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal discomfort, or a slow pulse. Should these symptoms appear, discontinue Glysuit M2 Tablet SR use and seek immediate medical attention.
Glysuit M2 SR tablets contain glimepiride and metformin, working synergistically to manage type 2 diabetes mellitus in adults. This medication enhances blood sugar control when coupled with a healthy diet and regular physical activity. Glimepiride stimulates pancreatic insulin secretion, reducing blood glucose. Metformin acts by decreasing hepatic glucose production and increasing insulin responsiveness. This combination therapy is unsuitable for type 1 diabetes.
Glysuit M2 Tablet SR may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, and headache. Rare but serious adverse reactions such as lactic acidosis are also possible. Prolonged treatment may result in vitamin B12 deficiency.
Prolonged Glysuit M2 Tablet SR use can indeed lead to Vitamin B12 deficiency. This medication impedes Vitamin B12 absorption within the gastrointestinal tract. Consequently, if left unaddressed, anemia and neurological complications may arise, manifesting as numbness and tingling in the extremities, generalized weakness, urinary dysfunction, cognitive impairment, and gait instability. Preventive measures, as proposed by some studies, include supplemental Vitamin B12 intake at least annually.
Glysuit M2 Tablet SR can indeed lead to hypoglycemia, characterized by low blood glucose. Manifestations of low blood sugar may encompass nausea, headache, irritability, hunger pangs, sweating, lightheadedness, a rapid heartbeat, and feelings of unease or tremor. These symptoms are more likely if meals are skipped or delayed, alcohol is consumed, excessive physical activity is undertaken, or other antidiabetic medications are concurrently used. Consequently, consistent blood glucose monitoring is crucial. Carrying a readily available fast-acting sugar source, such as glucose tablets, honey, or fruit juice, is advisable.
Consuming alcohol concurrently with Glysuit M2 Tablet SR is unsafe due to the risk of significantly reduced blood sugar (hypoglycemia) and a heightened probability of lactic acidosis.
Glysuit M2 Tablet SR
49
MRP 60
18% off